The emerging role of cytochrome P450 3A in psychopharmacology.
about
Role of cytochrome P450 in drug interactionsThe effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteersClinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsPathophysiological implications of neurovascular P450 in brain disordersA reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitroSummary of information on human CYP enzymes: human P450 metabolism data.Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.Clinically significant pharmacokinetic drug interactions with benzodiazepines.Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.Toxicological interactions involving psychiatric drugs and alcohol: an update.Safety of antidepressants in the elderly.Systematic review: ursodeoxycholic acid--adverse effects and drug interactions.Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications.Safety and tolerability of mood-stabilising anticonvulsants in the elderly.Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Modulation of cardiac cytochrome P450 in patients with heart failure.Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response.Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies.Urinary retention with fluoxetine-haloperidol combination in a young patient.Venlafaxine drug-drug interactions in clinical practice.Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo.No clinically relevant CYP3A induction with the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240.Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.Role of CYP3A5 in abnormal clearance of methadone.Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.Co-administration of Fluoxetine Alters the Steady State Pharmacokinetics of Fluconazole after Multiple Oral Administration in Dogs
P2860
Q21245066-B06AD7DA-5D3F-4F77-B7A6-2E2AC977C23CQ24564995-AD3D7390-AF84-41C9-BFBC-657AA0BB0297Q24610169-A987B381-E9D3-44F0-86E9-683012CFADE8Q26745632-8C8F33A1-A6AF-46B7-990A-86C2832E8415Q28374353-494629F1-A3F7-42ED-9649-618A34C31B50Q32103802-C4C71036-6D51-4B71-A929-00959FDF64D4Q33148910-23038C04-FA88-4B27-99CD-016897F4B9ADQ33785867-FE0A5BE7-ED3F-4182-B946-72E34AF3559EQ34429206-A42302CD-A6FB-4594-80B7-FCB984AB6B20Q35114132-5E540039-2184-460C-AE20-4B4713E96A33Q35194349-587D9676-D77C-478F-91D5-7FE6C8B3D620Q35583064-13124861-A54D-47A7-B853-B1B63314733FQ35646205-17C3F66F-4AA9-42D0-AE89-2B1FE434BBF2Q36446899-9AE000D9-6D15-4B51-89F6-32096A3F10D4Q38078561-40C9E4D3-4634-4EF7-B1B5-F47B0F55E9F4Q38175461-F632AD61-E3A9-412B-BC35-30CC2CA84D95Q38870014-AD8F57CA-FD0A-4F4E-9CC3-B62351D3154CQ41186979-4F7E1F6B-B373-4C7A-B9D2-0DFEBAC32259Q42552150-040B2458-0B36-454C-9F24-62D35A8B4FA5Q42940058-253D6AAA-9829-4027-870C-DB1D3CD5B6FFQ43854988-345136CC-DC15-4358-BC82-40CAAC5D9254Q44820367-98E27F01-E096-4DD4-BD52-0CC8417AA5C1Q46091944-314BE59D-5AB9-4157-914E-1F5C78BE19DBQ46609377-AEF21839-1828-465C-8FFC-5F7794FE0309Q46690421-BF9C44DF-FC45-4711-BDAC-DB306C1B92BAQ53857696-B6A3DF58-4261-4523-9DCD-1E218963DDC8Q58647372-5696BEFA-845D-4282-97C1-EBF739FA72AA
P2860
The emerging role of cytochrome P450 3A in psychopharmacology.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The emerging role of cytochrome P450 3A in psychopharmacology.
@en
type
label
The emerging role of cytochrome P450 3A in psychopharmacology.
@en
prefLabel
The emerging role of cytochrome P450 3A in psychopharmacology.
@en
P2093
P1476
The emerging role of cytochrome P450 3A in psychopharmacology.
@en
P2093
Callahan AM
Denicoff K
Flockhart DA
Marangell LB
Pazzaglia PJ
P304
P356
10.1097/00004714-199512000-00002
P407
P577
1995-12-01T00:00:00Z